Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Are Neutral on These Healthcare Stocks: Cross Country Healthcare (CCRN), HealthStream (HSTM)

Tipranks - Tue Mar 17, 7:02AM CDT

Analysts fell to the sidelines weighing in on Cross Country Healthcare (CCRNResearch Report) and HealthStream (HSTMResearch Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks.

Claim 70% Off TipRanks Premium

Cross Country Healthcare (CCRN)

Barrington analyst Kevin Steinke maintained a Hold rating on Cross Country Healthcare today. The company’s shares closed last Friday at $9.43.

According to TipRanks.com, Steinke is a 5-star analyst with an average return of 12.1% and a 52.5% success rate. Steinke covers the Industrial Goods sector, focusing on stocks such as Distribution Solutions Group, Mobile Infrastructure Corp, and Cra International. ;'>

The word on The Street in general, suggests a Hold analyst consensus rating for Cross Country Healthcare with a $11.67 average price target, which is a 20.8% upside from current levels. In a report issued on March 5, William Blair also maintained a Hold rating on the stock.

See the top stocks recommended by analysts >>

HealthStream (HSTM)

Barrington analyst Vincent Colicchio maintained a Hold rating on HealthStream today. The company’s shares closed last Friday at $20.30.

According to TipRanks.com, Colicchio is a 5-star analyst with an average return of 8.2% and a 52.1% success rate. Colicchio covers the Technology sector, focusing on stocks such as Information Services Group, Climb Global Solutions, and TD SYNNEX Corporation. ;'>

Currently, the analyst consensus on HealthStream is a Moderate Buy with an average price target of $30.50, representing a 50.3% upside. In a report issued on March 14, TipRanks – OpenAI also downgraded the stock to Hold with a $22.00 price target.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.